Bruno Guerci

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Maternally Inherited Diabetes and Deafness: A Multicenter Study

P.-J. Guillausseau, Pascale Massin, Danièle Dubois‐Laforgue et al. · Annals of Internal Medicine · 2001 · 306 citations

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study

Bruno Guerci, Pierre Drouin, Valerie Grange et al. · Diabetes & Metabolism · 2003 · 288 citations

Metabolic Syndrome, Diabetes Management, Health Policy +7

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)

Michael A. Nauck, Ruth S. Weinstock, Guillermo E. Umpierrez et al. · Diabetes Care · 2014 · 273 citations · Full text